Pharmaceutical

Can Musk’s BCI company Neuralink be trusted to put chip...

Musk announced Neuralink's first sucessful human BCI implant on Sunday, but can ...

Astellas seeks approval for Padcev-Keytruda combo thera...

Astellas has submitted an sNDA in Japan seeking approval for PADCEV with KEYTRUD...

CMS sets up negotiating framework for expensive sickle ...

CMS’ CGT Access Model will see allow the agency to negotiate negotiate pricing a...

Revolo advances plans to tackle eosinophilic esophagiti...

The FDA has granted an orphan drug designation to Revolo’s ‘1104, with plans for...

Out with the old, in with the new: Decoding biosimilar ...

As the UK pharmaceutical sector adopts the VPAG scheme, the question of how this...

Defender’s plans for motion sickness nasal gel stop wit...

The NASA and US Navy-propelled company remains confident, with Defender CEO Barr...

Biogen bids farewell to Aduhelm after tumultuous journe...

The shelving of Biogen’s troubled Alzheimer’s drug caps a turbulent journey, wit...

STAT+: Vertex pain drug results met with measured optim...

Trial results for a pain medication developed by Vertex Pharmaceuticals prompted...

STAT+: CMS will use outcomes-based agreements in bid to...

The U.S. government announced a long-awaited “access model” designed to blunt th...

The U.S. hasn’t seen syphilis numbers this high since 1...

The U.S. syphilis epidemic isn't abating, with the rate of infectious cases risi...

STAT+: Here are the new hotspots for Boston-area biotech

Never mind Kendall Square. In Massachusetts, the next miracle drug for lung canc...

Philips to stop selling sleep apnea machines in U.S. un...

Philips won't be able to sell new sleep apnea machines until it meets corrective...

How an immunological Trojan horse could treat disease

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: We’re reading about a Vertex pain ...

People who have severe pain but want to avoid the risk of opioid addiction are c...

STAT+: Vertex’s closely watched pain relief drug succee...

Results announced Tuesday by Vertex bring the biopharma giant a step closer to l...

STAT+: Cour Pharmaceuticals, a biotech taking aim at au...

Cour Pharmaceuticals, which announced a $105 million Series A round Tuesday, is ...